DHR vs KNSA · P/E 39, rev $6.26B vs P/E 53, rev $677.6M
Danaher Corporation (DHR) versus Kiniksa Pharmaceuticals Ltd (KNSA) — a side-by-side from cached financials, not a winner call.
Danaher Corporation (DHR) is a diagnostics & research company listed on US. It is led by Rainer M. Blair.
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
Latest reported DHR revenue for 2026-06-26 was $6.26B. Net income was $870.0M. Revenue was up 5.3% from 2026-03-27 to 2026-06-26. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
Latest reported KNSA revenue for 2025-12-31 was $677.6M. Net income was $59.0M. Revenue was up 60.1% from 2024-12-31 to 2025-12-31. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
DHR currently screens at market cap $144.18B and trailing P/E 39.0. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
Not investment advice. Open the DHR and KNSA stock pages for the full models.
Not investment advice.